Doctor Eduard Sidelnkov
Amgen (Europe) GmbH, Rotkreuz (Switzerland)
A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom
Event: ESC Congress 2020
Topic: Public Health
Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?
ESC 365 is supported by
